Andersen M, Wolter K, Enemark M, Pedersen M, Gormsen L, Lauridsen K
Eur J Haematol. 2024; 114(1):173-185.
PMID: 39394762
PMC: 11613579.
DOI: 10.1111/ejh.14326.
Jiang N, Saftics A, Romano E, Ghaeli I, Resto C, Robles V
J Nanobiotechnology. 2024; 22(1):589.
PMID: 39342336
PMC: 11438238.
DOI: 10.1186/s12951-024-02858-x.
Alsulami F, Shaheed S
Cancer Treat Res. 2024; 191:95-117.
PMID: 39133405
DOI: 10.1007/978-3-031-55622-7_4.
Theune W, Chen J, Theune E, Ye X, Menoret A, Vella A
Front Immunol. 2024; 15:1408710.
PMID: 38947320
PMC: 11211274.
DOI: 10.3389/fimmu.2024.1408710.
Ren X, Xue R, Luo Y, Wang S, Ge X, Yao X
Nat Commun. 2024; 15(1):5035.
PMID: 38866788
PMC: 11169524.
DOI: 10.1038/s41467-024-49482-9.
Tspan protein family: focusing on the occurrence, progression, and treatment of cancer.
Zhang H, Song Q, Shang K, Li Y, Jiang L, Yang L
Cell Death Discov. 2024; 10(1):187.
PMID: 38649381
PMC: 11035590.
DOI: 10.1038/s41420-024-01961-0.
Role of interferon-induced transmembrane protein family in cancer progression: a special focus on pancreatic cancer.
Wang P, Pan Y, Zhang Y, Chen C, Hu J, Wang X
Med Oncol. 2024; 41(4):85.
PMID: 38472606
DOI: 10.1007/s12032-024-02308-6.
Flt3L therapy increases the abundance of Treg-promoting CCR7 cDCs in preclinical cancer models.
Clappaert E, Kancheva D, Brughmans J, Debraekeleer A, Bardet P, Elkrim Y
Front Immunol. 2023; 14:1166180.
PMID: 37622122
PMC: 10445485.
DOI: 10.3389/fimmu.2023.1166180.
Tetraspanins set the stage for bone marrow microenvironment-induced chemoprotection in hematologic malignancies.
Quagliano A, Gopalakrishnapillai A, Barwe S
Blood Adv. 2023; 7(16):4403-4413.
PMID: 37561544
PMC: 10432613.
DOI: 10.1182/bloodadvances.2023010476.
The molecular mechanism of CD81 antibody inhibition of metastasis.
Abu-Saleh N, Kuo C, Jiang W, Levy R, Levy S
Proc Natl Acad Sci U S A. 2023; 120(26):e2305042120.
PMID: 37339209
PMC: 10293848.
DOI: 10.1073/pnas.2305042120.
CD81 and Its Relationship to Treatment Response in Patients With Acute Myeloid Leukemia at a Hospital in Hanoi, Vietnam.
Tuan Nguyen T, Lan Anh L, Ha Hong Q, Thi Vinh Do A
Cureus. 2023; 15(6):e40245.
PMID: 37309539
PMC: 10257809.
DOI: 10.7759/cureus.40245.
Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases.
Bailly C, Thuru X
Cancers (Basel). 2023; 15(7).
PMID: 37046846
PMC: 10093296.
DOI: 10.3390/cancers15072186.
Artesunate targets cellular metabolism to regulate the Th17/Treg cell balance.
Chen K, Tang L, Nong X
Inflamm Res. 2023; 72(5):1037-1050.
PMID: 37024544
DOI: 10.1007/s00011-023-01729-9.
IFITM protein regulation and functions: Far beyond the fight against viruses.
Friedlova N, Zavadil Kokas F, Hupp T, Vojtesek B, Nekulova M
Front Immunol. 2022; 13:1042368.
PMID: 36466909
PMC: 9716219.
DOI: 10.3389/fimmu.2022.1042368.
Machine learning-assisted elucidation of CD81-CD44 interactions in promoting cancer stemness and extracellular vesicle integrity.
Ramos E, Tsai C, Jia Y, Cao Y, Manu M, Taftaf R
Elife. 2022; 11.
PMID: 36193887
PMC: 9581534.
DOI: 10.7554/eLife.82669.
Roles of the RANKL-RANK Axis in Immunity-Implications for Pathogenesis and Treatment of Bone Metastasis.
Li B, Wang P, Jiao J, Wei H, Xu W, Zhou P
Front Immunol. 2022; 13:824117.
PMID: 35386705
PMC: 8977491.
DOI: 10.3389/fimmu.2022.824117.
Extracellular Vesicles as Signal Carriers in Malignant Thyroid Tumors?.
Grzanka M, Stachurska-Skrodzka A, Adamiok-Ostrowska A, Gajda E, Czarnocka B
Int J Mol Sci. 2022; 23(6).
PMID: 35328683
PMC: 8955189.
DOI: 10.3390/ijms23063262.
Single-cell RNA-seq of out-of-thaw mesenchymal stromal cells shows tissue-of-origin differences and inter-donor cell-cycle variations.
Medrano-Trochez C, Chatterjee P, Pradhan P, Stevens H, Ogle M, Botchwey E
Stem Cell Res Ther. 2021; 12(1):565.
PMID: 34736534
PMC: 8567133.
DOI: 10.1186/s13287-021-02627-9.
Single-Cell Cloning of Breast Cancer Cells Secreting Specific Subsets of Extracellular Vesicles.
Fathi M, Joseph R, Adolacion J, Martinez-Paniagua M, An X, Gabrusiewicz K
Cancers (Basel). 2021; 13(17).
PMID: 34503207
PMC: 8430892.
DOI: 10.3390/cancers13174397.
Targeting the tetraspanin CD81 reduces cancer invasion and metastasis.
Vences-Catalan F, Rajapaksa R, Kuo C, Miller C, Lee A, Ramani V
Proc Natl Acad Sci U S A. 2021; 118(24).
PMID: 34099563
PMC: 8214710.
DOI: 10.1073/pnas.2018961118.